PTSD (post-traumatic stress disorder) decisions — 2025

The Board granted a rating of 70 percent for PTSD and 40 percent for lumbosacral strain, but denied service connection for hypertension.

The Board denied an initial rating in excess of 30 percent for PTSD prior to November 4, 2022, and a rating in excess of 50 percent from November 4, 2022, to August 28, 2024. However, the Board granted a 70 percent rating, but no higher, for PTSD from August 29, 2024. The Board also remanded entitlement to service connection for sleep apnea.

The Board remands the claims for service connection for various conditions, including erectile dysfunction, PTSD, depression, frequent urination, intermetatarsal neuroma right foot, left knee condition, right knee condition, low back strain, shoulder strain, and tinnitus, due to a failure to provide necessary examinations.

The Veteran withdrew the appeals for both issues, and therefore they are dismissed.

The Board denied the veteran's claims for earlier effective dates and higher ratings, finding no evidence of entitlement to such benefits prior to the specified dates.

The Board remands the claim for service connection for post-traumatic stress disorder (PTSD) to verify the Veteran's reported in-service stressors and obtain a medical opinion.

The Board denied a rating in excess of 70 percent for PTSD with MDD, tobacco use disorder, and alcohol use disorder, as well as special monthly compensation based on the need for regular aid and attendance.

The Board granted an earlier effective date of January 14, 2009, for the award of service connection for PTSD but denied a claim to reverse or revise an October 2009 rating decision that denied service connection for PTSD on the basis of clear and unmistakable error.

The Board denied the Veteran's claim for an earlier effective date for the award of service connection for posttraumatic stress disorder, finding that June 10, 2022, is the appropriate effective date.

The Board denied the veteran's appeal for an increased rating in excess of 70 percent for his service-connected PTSD, finding that the evidence did not support a higher disability rating.

The Board denied the Veteran's claim for special monthly compensation (SMC) at the housebound rate as he does not meet the criteria.

The Board denied the Veteran's claim for service connection for an acquired psychiatric disorder, to include PTSD, as there was no current diagnosis of PTSD and the evidence did not support a link between any diagnosed condition and her military service.

The Board denied the Veteran's claim for a rating in excess of 70 percent for post-traumatic stress disorder (PTSD) as the severity, frequency, and duration of his symptoms did not more closely approximate total occupational and social impairment.

The Board denied service connection for posttraumatic stress disorder and alcohol use disorder as the evidence did not support a finding of in-service stressors or a diagnosis of alcohol use disorder.

The Board denied service connection for PTSD and alcohol use disorder as the record did not support the Veteran's claimed in-service stressors, and there was no evidence of a current diagnosis for alcohol use disorder.

The Board denied service connection for posttraumatic stress disorder (PTSD) as there is no current diagnosis of PTSD.

The Board remands the claim for an acquired psychiatric disorder to correct duty to assist errors, specifically regarding the adequacy of a VA examiner's opinion on the etiology of the Veteran's condition.

The Board denied the Veteran's claim for an earlier effective date for service connection for posttraumatic stress disorder (PTSD) due to clear and unmistakable error (CUE).

The Board remands the claims for service connection for PTSD and anxiety disorder, as well as a claim for TDIU, due to deficiencies in the development of evidence.

The Board granted service connection for squamous cell carcinoma of the tongue and assigned a 20 percent evaluation, but denied service connection for osteoporosis, spinal stenosis, neurocognitive disorder with Alzheimer's, hypertension, and TDIU.